GC18888
HNMPA-(AM)3
Also known as [bis(acetyloxymethoxy)phosphoryl-naphthalen-2-ylmethoxy]methyl acetate
HNMPA-(AM)3 is a cell-permeable prodrug form of the insulin receptor tyrosine kinase (IRTK) inhibitor HNMPA
ChemicalCAS120944-03-8MW454.4FormulaC20H23O10P
- CAS number
- 120944-03-8
- Molecular weight
- 454.4
- Formula
- C20H23O10P
- Solubility
- DMF： 15 mg/ml,DMSO： 1 mg/ml,Ethanol： 25 mg/ml,PBS (pH 7·2)： 1 mg/ml
- InChIKey
- UQODAZKXEREJLZ-UHFFFAOYSA-N
- Catalogue number
- GC18888
- Brand
- GLPBIO
Computed properties PubChem CID 3619 · XLogP 2.2 · TPSA 124 Ų · H-bond donors 0
- XLogP
- 2.2
- TPSA
- 124 Ų
- H-bond donors
- 0
- H-bond acceptors
- 10
- Rotatable bonds
- 14
- Heavy atoms
- 31
SMILES CC(=O)OCOC(C1=CC2=CC=CC=C2C=C1)P(=O)(OCOC(=O)C)OCOC(=O)C
Computed descriptors from PubChem (CID 3619), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il